triazoles has been researched along with Chromosomal Translocation in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammu, S; Bahlis, NJ; Baljevic, M; Ben-Shahar, O; Bensinger, WI; Bentur, OS; Biran, N; Callander, NS; Chen, CI; DeCastro, A; Gasparetto, C; Kauffman, M; Kotb, R; LeBlanc, R; Lentzsch, S; Lipe, B; Madan, S; Rossi, AC; Schiller, GJ; Sebag, M; Shacham, S; Shah, J; Sutherland, HJ; Tuchman, SA; Van Domelen, D; Venner, CP; White, D; Zhang, C; Zhou, T | 1 |
| Brill, B; Chilov, G; Haberbosch, I; Hoelzer, D; Metodieva, A; Mian, AA; Novikov, F; Ottmann, OG; Rafiei, A; Ruthardt, M; Stroganov, O; Stroylov, V; Titov, I; Zeifman, A | 1 |
| Acharya, P; Bradner, JE; Fischer, MA; Hiebert, SW; Kwak, H; Lis, JT; Liu, Q; Mohan, SR; Savona, MR; Sheng, Q; Stengel, KR; Strickland, SA; Venters, BJ; Zhao, Y; Zhou, MM; Zhou, X | 1 |
| Akçali, Z; Boğa, S; DemIrhan, B; Karakuş, S; Sahin, FI; Yilmaz, Z | 1 |
1 trial(s) available for triazoles and Chromosomal Translocation
| Article | Year |
|---|---|
Once weekly selinexor, carfilzomib and dexamethasone in carfilzomib non-refractory multiple myeloma patients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dexamethasone; Drug Administration Schedule; Female; Humans; Hydrazines; Male; Maximum Tolerated Dose; Middle Aged; Multiple Myeloma; Oligopeptides; Survival Analysis; Translocation, Genetic; Treatment Outcome; Triazoles | 2022 |
3 other study(ies) available for triazoles and Chromosomal Translocation
| Article | Year |
|---|---|
PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation.
Topics: Animals; Antigens, Ly; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; DNA Mutational Analysis; Female; fms-Like Tyrosine Kinase 3; Fusion Proteins, bcr-abl; Humans; Imidazoles; Inhibitory Concentration 50; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Proteins; Mice; Mice, Inbred C57BL; Models, Molecular; Mutagenesis; Mutation; Point Mutation; Proto-Oncogene Proteins c-kit; Pyridazines; Pyridines; Translocation, Genetic; Triazoles; Xenograft Model Antitumor Assays | 2015 |
High-Resolution Mapping of RNA Polymerases Identifies Mechanisms of Sensitivity and Resistance to BET Inhibitors in t(8;21) AML.
Topics: Antineoplastic Agents; Azepines; Cell Line, Tumor; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Clustered Regularly Interspaced Short Palindromic Repeats; DNA-Directed RNA Polymerases; Drug Resistance, Neoplasm; Enhancer Elements, Genetic; Gene Expression Regulation, Leukemic; High-Throughput Nucleotide Sequencing; Humans; Leukemia, Myeloid, Acute; MicroRNAs; Multigene Family; Myeloid Cell Leukemia Sequence 1 Protein; Promoter Regions, Genetic; Protein Isoforms; Proteins; Proto-Oncogene Proteins c-kit; Transcription, Genetic; Translocation, Genetic; Triazoles | 2016 |
t(8;16) AML developed subsequent to breast cancer therapy.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Estrogens; Fatal Outcome; Female; Fluorouracil; Humans; Idarubicin; Leukemia, Myelomonocytic, Acute; Mastectomy, Modified Radical; Middle Aged; Neoplasms, Hormone-Dependent; Neoplasms, Multiple Primary; Neoplasms, Second Primary; Nitriles; Radiotherapy, Adjuvant; Translocation, Genetic; Triazoles | 2006 |